WashU Team Uses Sequencing to Unravel Patterns Underlying AML Relapse | GenomeWeb

By Andrea Anderson

NEW YORK (GenomeWeb News) – Using whole-genome sequencing and targeted deep sequencing on tumor and normal samples from several individuals with acute myeloid leukemia, a Washington University team has uncovered some of the patterns contributing to AML relapse after treatment.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.